These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1528049)
1. Impaired hepatic energy metabolism in rat acute pancreatitis: protective effects of prostaglandin E2 and synthetic protease inhibitor ONO 3307. Hirano T; Manabe T; Tobe T J Surg Res; 1992 Sep; 53(3):238-44. PubMed ID: 1528049 [TBL] [Abstract][Full Text] [Related]
2. Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis. Hirano T; Manabe T; Tobe T Am J Med Sci; 1992 Sep; 304(3):154-63. PubMed ID: 1282294 [TBL] [Abstract][Full Text] [Related]
3. Effects of acute pancreatitis on hepatic secretion of lysosomal enzymes into bile and hepatic lysosomal fragility: protective effects of a new synthetic protease inhibitor, ONO 3307. Hirano T; Manabe T; Calne R; Tobe T Scand J Gastroenterol; 1992; 27(3):227-32. PubMed ID: 1502486 [TBL] [Abstract][Full Text] [Related]
4. Effect of prostaglandin E2 on cellular, lysosomal and mitochondrial fragility in caerulein-induced pancreatitis in rats. Manabe T; Hirano T; Ando K; Yotsumoto F; Tobe T Hepatogastroenterology; 1993 Oct; 40(5):463-6. PubMed ID: 8270235 [TBL] [Abstract][Full Text] [Related]
5. Changes in hepatic energy metabolism in experimental acute pancreatitis. Yan LN; Ozawa K; Kobayashi N Chin Med J (Engl); 1992 Aug; 105(8):684-8. PubMed ID: 1458973 [TBL] [Abstract][Full Text] [Related]
6. Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007. Hirano T; Manabe T; Tobe T Pharmacology; 1992; 45(2):107-16. PubMed ID: 1381836 [TBL] [Abstract][Full Text] [Related]
7. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis. Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204 [TBL] [Abstract][Full Text] [Related]
8. [Changes in hepatic energy metabolism in rats with acute necrotizing pancreatitis]. Yan LN Zhonghua Wai Ke Za Zhi; 1990 May; 28(5):295-7, 318-9. PubMed ID: 2086101 [TBL] [Abstract][Full Text] [Related]
9. A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis. Hirano T; Manabe T; Imanishi K; Yotsumoto F; Kyogoku T; Tobe T Nihon Geka Hokan; 1991 Nov; 60(6):406-14. PubMed ID: 1820013 [TBL] [Abstract][Full Text] [Related]
10. Gastric subcellular organelle fragility and impaired gastric energy charge levels in rats with caerulein-induced acute pancreatitis: protective effect of anti-ulcer agent, teprenone. Hirano T J Int Med Res; 1994; 22(3):165-70. PubMed ID: 8088424 [TBL] [Abstract][Full Text] [Related]
11. A new synthetic protease inhibitor, E-3123, prevents lysosomal and mitochondrial fragility in rat caerulein-induced pancreatitis. Hirano T; Manabe T J Int Med Res; 1992 Jun; 20(3):211-7. PubMed ID: 1383065 [TBL] [Abstract][Full Text] [Related]
12. Effect of prostaglandin E on the redistribution of lysosomal enzymes in caerulein-induced pancreatitis. Hirano T; Manabe T; Yotsumoto F; Ando K; Imanishi K; Tobe T Hepatogastroenterology; 1993 Apr; 40(2):155-8. PubMed ID: 7685311 [TBL] [Abstract][Full Text] [Related]
13. Hepatic mitochondrial and lysosomal alterations in acute experimental pancreatitis with ethanolic coetiology in rats. Poplawski C; Dlugosz JW; Gabryelewicz A; Pawlicka E; Wróblewski E; Adrzejewska A Dig Dis Sci; 1996 Jan; 41(1):139. PubMed ID: 8565747 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of gabexate mesilate (FOY) against impaired pancreatic energy metabolism in rat acute pancreatitis induced by caerulein. Hirano T; Manabe T; Tobe T Life Sci; 1991; 49(22):PL179-84. PubMed ID: 1719326 [TBL] [Abstract][Full Text] [Related]
15. [The cellular and lysosomal fragility of pancreatic acinar cells after ligation of pancreatico-biliary duct in the rat and the protective effects of nafamostat mesilate]. Hirano T; Manabe T; Tobe T Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1489-500. PubMed ID: 1283776 [TBL] [Abstract][Full Text] [Related]
16. Influence of the beta-hydroxybutyrate/acetoacetate ratio on the redox states of mitochondrial NAD(P) and cytochrome c systems, extramitochondrial ATP/ADP ratio and the respiration of isolated liver mitochondria in the resting state. Schönfeld P; Bohnensack R; Böhme G; Kunz W Biomed Biochim Acta; 1983; 42(1):3-13. PubMed ID: 6309158 [TBL] [Abstract][Full Text] [Related]
17. Significance of blood ketone body ratio as an indicator of hepatic cellular energy status in jaundiced rabbits. Tanaka J; Ozawa K; Tobe T Gastroenterology; 1979 Apr; 76(4):691-6. PubMed ID: 421996 [TBL] [Abstract][Full Text] [Related]
18. Human urinary trypsin inhibitor, urinastatin, prevents pancreatic injuries induced by pancreaticobiliary duct obstruction with cerulein stimulation and systemic hypotension in the rat. Hirano T; Manabe T Arch Surg; 1993 Dec; 128(12):1322-9; discussion 1329. PubMed ID: 7504442 [TBL] [Abstract][Full Text] [Related]
19. Acute responses of blood ketone body ratio following devascularization and revascularization of rabbit liver. Noguchi M; Tanaka A; Taki Y; Shimahara Y; Kamiyama Y; Ozawa K Eur Surg Res; 1987; 19(5):290-7. PubMed ID: 3653157 [TBL] [Abstract][Full Text] [Related]
20. [Changes of acinar cells in the pancreato-biliary duct ligation with exocrine pancreatic stimulation model in rats; protective effects of a new potent protease inhibitor, ONO3307]. Hirano T; Yotsumoto TM; Ando K; Tobe T Nihon Geka Hokan; 1991 Sep; 60(5):342-53. PubMed ID: 1726453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]